GB0904300D0 - Essential fatty acid compounds - Google Patents

Essential fatty acid compounds

Info

Publication number
GB0904300D0
GB0904300D0 GBGB0904300.1A GB0904300A GB0904300D0 GB 0904300 D0 GB0904300 D0 GB 0904300D0 GB 0904300 A GB0904300 A GB 0904300A GB 0904300 D0 GB0904300 D0 GB 0904300D0
Authority
GB
United Kingdom
Prior art keywords
fatty acid
acid compounds
essential fatty
essential
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0904300.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amarin Neuroscience Ltd
Original Assignee
Amarin Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Neuroscience Ltd filed Critical Amarin Neuroscience Ltd
Priority to GBGB0904300.1A priority Critical patent/GB0904300D0/en
Publication of GB0904300D0 publication Critical patent/GB0904300D0/en
Priority to AU2010222692A priority patent/AU2010222692A1/en
Priority to CA2754902A priority patent/CA2754902A1/en
Priority to PCT/GB2010/000430 priority patent/WO2010103273A2/en
Priority to JP2011553508A priority patent/JP2012520274A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0904300.1A 2009-03-12 2009-03-12 Essential fatty acid compounds Ceased GB0904300D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0904300.1A GB0904300D0 (en) 2009-03-12 2009-03-12 Essential fatty acid compounds
AU2010222692A AU2010222692A1 (en) 2009-03-12 2010-03-10 Essential fatty acid compounds
CA2754902A CA2754902A1 (en) 2009-03-12 2010-03-10 Essential fatty acid compounds
PCT/GB2010/000430 WO2010103273A2 (en) 2009-03-12 2010-03-10 Essential fatty acid compounds
JP2011553508A JP2012520274A (en) 2009-03-12 2010-03-10 Essential fatty acid compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0904300.1A GB0904300D0 (en) 2009-03-12 2009-03-12 Essential fatty acid compounds

Publications (1)

Publication Number Publication Date
GB0904300D0 true GB0904300D0 (en) 2009-04-22

Family

ID=40600956

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0904300.1A Ceased GB0904300D0 (en) 2009-03-12 2009-03-12 Essential fatty acid compounds

Country Status (5)

Country Link
JP (1) JP2012520274A (en)
AU (1) AU2010222692A1 (en)
CA (1) CA2754902A1 (en)
GB (1) GB0904300D0 (en)
WO (1) WO2010103273A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2873093A1 (en) * 2012-05-07 2013-11-14 Cellixbio Private Limited Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
AU2014214055A1 (en) * 2013-02-05 2015-07-16 Teva Pharmaceuticals International Gmbh Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
WO2019097120A1 (en) 2017-11-16 2019-05-23 Orion Corporation New use and pharmaceutical dosage forms
CN110041300A (en) 2019-02-18 2019-07-23 海南大学 A kind of pharmaceutical intermediate compound and its synthetic method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85757A1 (en) * 1985-02-04 1986-09-02 Univ Catholique Louvain NOVEL L-DOPA DERIVATIVES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS RELATING TO SUCH COMPOUNDS
WO1998016216A1 (en) 1996-10-11 1998-04-23 Scotia Holdings Plc Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
GB9901809D0 (en) 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
EP1751087B1 (en) * 2004-06-04 2012-06-27 XenoPort, Inc. Levodopa derivatives, and compositions and uses thereof
WO2008079387A1 (en) * 2006-12-21 2008-07-03 Xenoport, Inc. Catechol protected levodopa diester prodrugs, compositions, and methods of use

Also Published As

Publication number Publication date
JP2012520274A (en) 2012-09-06
AU2010222692A1 (en) 2011-10-13
WO2010103273A3 (en) 2010-11-04
WO2010103273A2 (en) 2010-09-16
CA2754902A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
IL215691A0 (en) Carboxylic acid compound
SI2421808T1 (en) 4-hydroxybutyric acid analogs
EP2483254A4 (en) Novel compounds
GB0905955D0 (en) Novel compounds
EP2483233A4 (en) Heteroatom containing substituted fatty acids
EP2459189A4 (en) Fatty acids as anti-inflammatory agents
ZA201108850B (en) Solid compositions comprising 5-aminolevulinic acid
IL214887A0 (en) Fatty acid monoglyceride compositions
EP2542232A4 (en) Fatty acid inhibitors
ZA201203039B (en) Sunscreen composition with fatty acid alkanolamides
EP2512242A4 (en) Novel compounds
GB0910674D0 (en) Novel compounds
GB0904300D0 (en) Essential fatty acid compounds
GB0910009D0 (en) Novel compounds
GB0910667D0 (en) Novel compounds
GB0907105D0 (en) Novel compounds
GB0907121D0 (en) Novel compounds
GB0906571D0 (en) Novel compounds
GB0906577D0 (en) Novel compounds
GB0906578D0 (en) Novel compounds
GB0907104D0 (en) Novel compounds
GB0906048D0 (en) Novel compounds
GB0907106D0 (en) Novel compounds
GB0907107D0 (en) Novel compounds
GB0907112D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)